THE HIGHLANDS PHARMACY LIMITEDActive
Key figures
THE HIGHLANDS PHARMACY LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £75,000 (64% of the profit for the year).
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | — | — | — | 104,408 | 116,809 |
| Cash at bank and in hand | 118,001 | 160,957 | 49,222 | 102,499 | 137,666 |
| Total assets | 433,493 | 380,852 | 293,797 | 367,780 | 419,163 |
| Total liabilities | 311,483 | 281,742 | 262,701 | 283,436 | — |
| Net assets / total equity | 134,994 | 119,150 | 47,434 | 93,842 | 135,651 |
| Average number of employees | 14 | 16 | 16 | 24 | 0 |
| Dividends paid | — | — | — | 58,000 | 75,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: THE HIGHLANDS PHARMACY LIMITED
Company
THE HIGHLANDS PHARMACY LIMITED is a private limited company registered with Companies House under company number 06521889. It was incorporated on 3 Mar 2008. Its status is active. The registered office is in Luton (LU3). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Profit for the year was £116,809. Net assets were £135,651, up 44.6% on the previous year. Cash at bank and in hand was £137,666. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered. 2 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 17 Mar 2027.